![]() |
市場調查報告書
商品編碼
1918127
PPG生物感測器市場-2026-2031年預測PPG Biosensors Market - Forecast from 2026 to 2031 |
||||||
PPG 生物感測器市場預計將從 2025 年的 4.8218 億美元成長到 2031 年的 8.95737 億美元,維持 10.87% 的複合年成長率。
受心血管疾病高發生率、穿戴式科技融合以及醫療服務模式不斷發展的推動,光電容積脈搏波描記法(PPG)生物感測器市場正經歷顯著擴張。這些分析設備透過光訊號檢測化學物質,並將生物反應轉化為電脈衝,正日益整合到各種形狀的設備中,包括戒指、手錶、貼片和耳塞。 PPG生物感測器採用運動容錯技術,發射光訊號持續記錄皮膚血流指標,從而實現多種臨床和消費應用領域的即時健康監測。
主要市場促進因素
心血管疾病負擔
心血管疾病發生率的不斷上升是光電容積脈搏波描記法(PPG)生物感測器市場成長的根本成長要素。在美國,至少有48%的人患有心血管疾病,因此產生了巨大的監測需求。將PPG技術與先進功能結合,能夠顯著加快心臟疾病的檢測速度,透過遠端患者監護增強醫療效果,並降低心血管疾病相關的死亡率。 PPG是一種經濟高效、非侵入性的ECG感測器替代方案,能夠監測包括手指、腳指、耳朵、手腕、胸部和頭部在內的多個解剖部位的訊號。這種多功能性和易用性使得PPG生物感測器在更廣泛的心血管疾病管理中具有特別重要的價值,因為心血管疾病仍然是全球首要死因。預測顯示,到2035年,將有超過1.3億人(佔總人口的45.1%)患有心血管疾病,凸顯了市場需求的持續成長。
智慧型手錶整合
智慧型手錶市場的蓬勃發展是推動光電容積脈搏波描記法(PPG)生物感測器普及應用的主要動力。這些生物感測器正日益整合到消費級智慧型手錶中,用於監測佩戴者在運動、睡眠和日常活動中的健康狀況。 2021年,美國智慧型手錶銷售量預計將達到2,010萬塊,其中大部分將配備以光電容積脈搏波描記法(PPG)為基礎的心率監測器。包括Apple Watch、Fitbit和Garmin在內的眾多領先智慧型手錶都已採用PPG技術,這標誌著該技術在消費市場的主流化應用,也為PPG生物感測器製造商帶來了可觀的銷售量。
心率監測應用
光電容積脈搏波描記法(PPG)技術已在配備心率監測器的智慧服裝領域廣泛應用。市場按應用領域可細分為心率監測、血氧飽和度監測、血壓監測以及其他功能,例如呼吸和睡眠監測。由於心血管疾病(CVD)患者需要持續監測,而心血管疾病是全球首要死因,因此持續心率監測在臨床和預防保健中都變得越來越重要。
脈搏血氧飽和度分析儀的發展
在脈動式血氧監測儀系統正經歷尤為迅猛的成長。脈搏血氧計飽和度監測是一種非侵入性測量動脈血氧飽和度的方法,也是雙波長PPG技術的主要應用領域之一。穿戴式監測設備需求的成長、心血管疾病發生率的上升、人口老化以及智慧脈動式血氧監測儀系統市場的擴張,都推動了PPG生物感測器市場的成長。基於應用程式的監測解決方案的出現,使用戶能夠透過智慧型手機應用程式追蹤血氧飽和度,進一步普及了生命徵象監測。
遠端患者監護的需求
遠端患者監護解決方案正在變革醫療服務模式,而光電容積脈搏波描記法(PPG)生物感測器在這項變革中發揮核心作用。這些生物感測器提供了一種非侵入性且便捷的方式來監測心率、血氧飽和度和呼吸頻率等生命徵象,滿足了人們日益成長的居家醫療偏好以及對慢性病持續監測的需求。遠端醫療正在蓬勃發展,尤其是在農村和醫療資源匱乏的地區,PPG生物感測器使醫護人員能夠在遠距就診期間即時查看患者的生命徵象。這種能力使得高品質的遠端醫療得以實現,而這在缺乏面對面就診的情況下是無法實現的。
創新與協作
穿戴式科技的快速發展,例如感測器尺寸的縮小、電池續航時間的延長以及無線通訊的普及,正在推動對光電容積脈搏波描記法(PPG)生物感測器的需求。技術進步使得PPG生物感測器更容易整合到各種穿戴式裝置中,從而實現無縫的生命徵象監測。智慧型手錶、健身手環和穿戴式科技平台的日益普及進一步推動了市場成長。
多家公司和學術機構正積極合作,致力於提升光電容積脈搏波描記法(PPG)生物感測器的性能。穿戴式科技製造商、醫學專家和生物感測器開發商之間的夥伴關係正在推動該領域的發展。這些合作催生了性能更優、電池續航時間更長、精度更高的PPG生物感測器,從而對市場發展產生了積極影響。
區域和近期趨勢
由於心血管疾病的日益普遍以及價格適中的穿戴式生物感測器的廣泛應用,預計北美將佔據最大的市場佔有率。亞太地區預計將實現快速成長,這得益於已開發智慧型手錶的普及以及供應商對開發能夠即時測量多種異常情況的光電容積脈搏波描記法(PPG)生物感測器的投資。
2023 年 2 月,Holtek 發布了 BH66F2560脈搏血氧飽和度分析儀微控制器,該微控制器具有出色的功能整合、精度和低雜訊特性,展現了 PPG 生物感測器技術的持續創新。
它是用來做什麼的?
產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響
The PPG Biosensors market, sustaining a 10.87% CAGR, is projected to expand from USD 482.180 million in 2025 to USD 895.737 million in 2031.
The PPG (photoplethysmography) biosensors market is experiencing substantial expansion driven by cardiovascular disease prevalence, wearable technology integration, and evolving healthcare delivery models. These analytical devices, which convert biological reactions into electrical impulses by detecting chemical substances through light signals, are increasingly embedded in diverse form factors including rings, watches, patches, and earbuds. PPG biosensors utilize motion-tolerant technology to emit light signals that continuously record skin indicators of blood flow, enabling real-time health monitoring across multiple clinical and consumer applications.
Primary Market Drivers
Cardiovascular Disease Burden
The rising incidence of cardiovascular diseases represents a fundamental growth catalyst for the PPG biosensors market. At least 48% of individuals in the United States have cardiovascular disease, creating substantial monitoring demands. Integrating PPG technology with advanced capabilities significantly accelerates cardiopathy detection, enhances medical treatment through remote patient monitoring, and reduces CVD-related fatalities. PPG offers a cost-effective, non-invasive alternative to ECG sensors, capable of monitoring signals at multiple anatomical sites including fingers, toes, ears, wrists, chest, and head. This versatility and accessibility make PPG biosensors particularly valuable for widespread CVD management, as cardiovascular disease remains the leading cause of mortality worldwide. Projections indicate that by 2035, more than 130 million individuals-representing 45.1% of the population-will have CVD, underscoring sustained market demand.
Smartwatch Integration
The expanding smartwatch market significantly propels PPG biosensor adoption. These biosensors are increasingly integrated into consumer smartwatches to monitor wearers' health during movement, sleep, and daily activities. In 2021, 20.1 million smartwatches were sold in the U.S., with the majority incorporating photoplethysmography-based heart rate monitors. Leading products including Apple Watch, Fitbit, Garmin, and numerous other smartwatches rely on PPG technology, demonstrating the technology's mainstream consumer acceptance and creating substantial volume for PPG biosensor manufacturers.
Heart Rate Monitoring Applications
PPG technology finds primary application in smart clothing featuring heart rate monitors. The market segments by application into heart rate monitoring, blood-oxygen saturation monitoring, blood pressure monitoring, and other functions including respiration and sleep monitoring. Given that individuals with CVD require constant monitoring and cardiovascular disease represents the leading global mortality cause, continuous heart rate monitoring capabilities are increasingly critical for both clinical and preventive care applications.
Pulse Oximeter Growth
Pulse oximeters are experiencing particularly rapid growth within the PPG biosensors market. Pulse oximetry-a noninvasive method of calculating arterial oxygen saturation-represents the primary application of dual-wavelength PPG technology. The growing demand for wearable monitoring devices, CVD incidence, aging populations, and smart pulse oximeter market expansion all contribute to PPG biosensor market growth. Application-based monitoring solutions are emerging, enabling users to track oxygen saturation levels through smartphone applications, further democratizing access to vital sign monitoring.
Remote Patient Monitoring Demand
Remote patient monitoring solutions are transforming healthcare delivery, with PPG biosensors playing central roles in this evolution. These biosensors provide non-invasive, practical methods for monitoring vital signs including heart rate, blood oxygen saturation, and respiratory rate, aligning with preferences for home-based healthcare and rising needs for continuous chronic condition monitoring. Telemedicine has expanded significantly, particularly in rural and underserved areas, with PPG biosensors providing medical practitioners real-time access to patients' vital signs during virtual consultations. This capability enables quality remote care delivery previously impossible without in-person examination.
Technological Innovation and Collaboration
Rapid advancements in wearable technology-including sensor miniaturization, extended battery life, and wireless communication-are fueling PPG biosensor demand. Technical progress enables easier integration into diverse wearable devices, facilitating seamless vital sign monitoring. The growing popularity of smartwatches, fitness bands, and wearable technology platforms further stimulates market growth.
Multiple companies and academic institutions actively collaborate to enhance PPG biosensor capabilities. Partnerships among wearable technology manufacturers, healthcare professionals, and biosensor developers foster sector advancements. These collaborations yield upgraded PPG biosensors with increased connectivity, longer battery life, and greater accuracy, favorably impacting market development.
Regional Dynamics and Recent Developments
North America is anticipated to control maximum market share due to increased cardiovascular disease prevalence and widespread availability of affordable wearable biosensors. The Asia-Pacific region is predicted to experience rapid growth as smartwatch popularity increases in developed countries and vendors invest in developing PPG biosensors capable of measuring multiple anomalies in real-time.
In February 2023, Holtek announced the BH66F2560 Pulse Oximeter MCU, featuring excellent functional integration, precision, and low noise characteristics, demonstrating ongoing innovation in PPG biosensor technology.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence